Computational AI tool for predicting therapy response
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
The clinical trial has started
13 out of 29 study centres in Austria, Germany and Poland have begun recruiting participants for the trial of the PoCCardio point-of-care solution.
Novel clustering algorithm for enhancing the interpretability in patient stratification
The paper was prepared by the Medical University of Graz for the CIBB 2024 conference on Computational Intelligence methods for Bioinformatics and Biostatistics.
A new project partner
PoCCardio welcomes the Bioinformatics Department at CING - The Cyprus Institute of Neurology and Genetics
Project leaflet released
Have a look at our leaflet
PoCCardio on Austrian TV
Mobile device to replace laboratory tests
